March 2006
Biophan: Planets Aligned for Share Price Rise.
March 05, 2006
Biophan: Planets Aligned for Share Price Rise. Biophan (OTCBB: BIPH) announced Friday (release below) that it has secured a collaboration with material sciences company NaturalNano (OTCBB: NNAN) regarding the use of ultra-tiny, hollow Halloysite nanotubes for the enhancement of several critical biomedical...
Biophan: Planets Aligned for Share Price Rise. Biophan (OTCBB: BIPH) announced Friday (release below) that it has secured a collaboration with material sciences company NaturalNano (OTCBB: NNAN) regarding the use of ultra-tiny, hollow Halloysite nanotubes for the enhancement of several critical biomedical...
December 2005
Feature: 2005 in Review - Beauties and the Beasts.
December 21, 2005
Feature: 2005 in Review - Beauties and the Beasts. I’m not going to belabor the fact that the Santa rally hasn’t materialized for the smallcaps this year. As a matter of fact, the fall pretty much sucked out loud for the genre. Along with some good wins, along with everyone else, we also took some lumps...
Feature: 2005 in Review - Beauties and the Beasts. I’m not going to belabor the fact that the Santa rally hasn’t materialized for the smallcaps this year. As a matter of fact, the fall pretty much sucked out loud for the genre. Along with some good wins, along with everyone else, we also took some lumps...
Feature: Biophan - Good for Hearts...Great for Portfolios.
December 02, 2005
Feature: Biophan - Good For Hearts...Great for Portfolios. The late entrepreneur Victor Kiam came to fame and fortune with the phrase: “I liked the product so much, I bought the company”. Mr. Kiam would certainly have approved of next generation medical device company Biophan’s (OTCBB: BIPH) announcement...
Feature: Biophan - Good For Hearts...Great for Portfolios. The late entrepreneur Victor Kiam came to fame and fortune with the phrase: “I liked the product so much, I bought the company”. Mr. Kiam would certainly have approved of next generation medical device company Biophan’s (OTCBB: BIPH) announcement...
November 2005
Feature: Biophan - Shares and Sector Ready to Rock?
November 05, 2005
Feature: Biophan - Shares and Sector Ready to Rock? Followers of Biophan (OTCBB: BIPH) (and longtime SmallCap Digest readers) are well aware of its impressive licensing relationship with behemoth Boston Scientific (NYSE: BSX). If not, reread our July 16th piece detailing the terms. Further, Biophan updated the state of the relationship with BSX in a release today. The recent BIPH share price pullback—which could be due in part to the recent weakness in BSX shares - looks to us to be a great risk/reward bet for grabbing some shares of Biophan ( and BSX as well) at oversold prices. I shall explain...
Feature: Biophan - Shares and Sector Ready to Rock? Followers of Biophan (OTCBB: BIPH) (and longtime SmallCap Digest readers) are well aware of its impressive licensing relationship with behemoth Boston Scientific (NYSE: BSX). If not, reread our July 16th piece detailing the terms. Further, Biophan updated the state of the relationship with BSX in a release today. The recent BIPH share price pullback—which could be due in part to the recent weakness in BSX shares - looks to us to be a great risk/reward bet for grabbing some shares of Biophan ( and BSX as well) at oversold prices. I shall explain...
September 2005
Feature: Biophan - Rebound Imminent.
September 25, 2005
Feature: Biophan - Rebound Imminent. Love or just like it, Biophan (OTCBB: BIPH), has been old reliable in the profit column for subscribers of the SmallCap Digest. In December of ’03 when we first featured it at $.35, BIPH was completely unknown and possessed some interesting technology in the nanotechnology...
Feature: Biophan - Rebound Imminent. Love or just like it, Biophan (OTCBB: BIPH), has been old reliable in the profit column for subscribers of the SmallCap Digest. In December of ’03 when we first featured it at $.35, BIPH was completely unknown and possessed some interesting technology in the nanotechnology...
Feature: Biophan Trends Up. Superclick Oversold?
September 09, 2005
Feature: Biophan Trends Up. Superclick Oversold? Medical device and nano-development company Biophan (OTCBB: BIPH) has made phenomenal progress since we began covering the Rochester-based company in December 2003 at 35 cents. At a current level of $2.60, even though readers have enjoyed almost a 650...
Feature: Biophan Trends Up. Superclick Oversold? Medical device and nano-development company Biophan (OTCBB: BIPH) has made phenomenal progress since we began covering the Rochester-based company in December 2003 at 35 cents. At a current level of $2.60, even though readers have enjoyed almost a 650...
July 2005
Feature: Biophan/BSX Details. Biotech Booms. Drugs Loom.
July 16, 2005
Feature: Biophan/BSX Details. Biotech Booms. Drugs Loom. As a backdrop against some great Biophan news—more on that in a moment—we thought it would be useful to update our views on the biotech market and take a moment to discuss the drug sector as a constituent within the sector. We think you’ll find...
Feature: Biophan/BSX Details. Biotech Booms. Drugs Loom. As a backdrop against some great Biophan news—more on that in a moment—we thought it would be useful to update our views on the biotech market and take a moment to discuss the drug sector as a constituent within the sector. We think you’ll find...
June 2005
Feature: Once Around the Stable - Biophan, Biocurex et al...
June 22, 2005
Feature: Once Around the Stable - Biophan, BioCurex et al… Received some great emails on our educational/big cap strategy pieces over the last week. We like to mix it up a bit so if you have any market topics you’d like to see us cover—no matter how basic you may think they are-- send ‘em in here. Or...
Feature: Once Around the Stable - Biophan, BioCurex et al… Received some great emails on our educational/big cap strategy pieces over the last week. We like to mix it up a bit so if you have any market topics you’d like to see us cover—no matter how basic you may think they are-- send ‘em in here. Or...
Feature: Biotech - The Next Big Boom?
June 14, 2005
Feature: Biotech - The Next Big Boom? For the most part, Biotech companies don’t trade on fundamentals. They are trade on the three ‘P’s”: potential, pipeline and vision. OK, two p’s and a v. Even senior companies’ prices--such as Genentech (NYSE: DNA) --look positively goofy if you try to rationalize...
Feature: Biotech - The Next Big Boom? For the most part, Biotech companies don’t trade on fundamentals. They are trade on the three ‘P’s”: potential, pipeline and vision. OK, two p’s and a v. Even senior companies’ prices--such as Genentech (NYSE: DNA) --look positively goofy if you try to rationalize...
Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue
June 07, 2005
Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue Flows. Biophan (OTCBB: BIPH) CEO Michael Weiner recently stated: “There is no longer any excuse for not making and certifying devices to be safe with MRI machines.” And he should know. Biophan now holds 127 issued or pending US patents...
Feature: Bio Advances - Biophan, MIV Therapeutics. Stream's Revenue Flows. Biophan (OTCBB: BIPH) CEO Michael Weiner recently stated: “There is no longer any excuse for not making and certifying devices to be safe with MRI machines.” And he should know. Biophan now holds 127 issued or pending US patents...
May 2005
Feature: Biophan - Full Steam Ahead.
May 27, 2005
Feature: Biophan - Full Steam Ahead. Biophan (OTCBB: BIPH), A Company we first initiated coverage on at a mere $.35 cents back in December of 2003, has been one of the SmallCap Digest’s best performers to date yielding nearly a 600% return since we first published on this unique story. For those of...
Feature: Biophan - Full Steam Ahead. Biophan (OTCBB: BIPH), A Company we first initiated coverage on at a mere $.35 cents back in December of 2003, has been one of the SmallCap Digest’s best performers to date yielding nearly a 600% return since we first published on this unique story. For those of...
August 2004
Feature: Biophan Follow-Up. Patent Numbers Really Rise.
August 20, 2004
Feature: Biophan follow-up. Patent numbers really rise. Just before I embark on the annual family road-trip—back Wednesday-- a quick follow-up on nano biotech Biophan (OTCBB: BIPH). I don’t usually do two pieces in a row on a company, but the relevant news flow out of NY-based Biophan is coming both...
Feature: Biophan follow-up. Patent numbers really rise. Just before I embark on the annual family road-trip—back Wednesday-- a quick follow-up on nano biotech Biophan (OTCBB: BIPH). I don’t usually do two pieces in a row on a company, but the relevant news flow out of NY-based Biophan is coming both...
Feature: Biophan - Will Lightning Strike Twice?
August 17, 2004
Feature: Biophan - Will Lightning strike twice? Long time readers of SmallCap Digest will remember, fondly, our previous Alert last December of nanotech firm Biophan (OTCBB: BIPH). We Alerted the readership initially when this small company was at 35 cents. Less than 45 days later the shares had advanced...
Feature: Biophan - Will Lightning strike twice? Long time readers of SmallCap Digest will remember, fondly, our previous Alert last December of nanotech firm Biophan (OTCBB: BIPH). We Alerted the readership initially when this small company was at 35 cents. Less than 45 days later the shares had advanced...
January 2004
Feature: Biophan - Financing Means Opportunity.
January 30, 2004
Feature: Biophan: Financing means opportunity. SmallCap readers are well aware that nanotechnology concern Biophan (OTCBB: BIPH) can be both volatile and very profitable. We Alerted the readership to accumulate BIPH at 35 cents in late December, and advised taking partial profits at the $1.50 level...
Feature: Biophan: Financing means opportunity. SmallCap readers are well aware that nanotechnology concern Biophan (OTCBB: BIPH) can be both volatile and very profitable. We Alerted the readership to accumulate BIPH at 35 cents in late December, and advised taking partial profits at the $1.50 level...
Profit Alert: Biophan; Nothing short of breathtaking.
January 12, 2004
Profit Alert: Biophan; Nothing short of breathtaking. I love it when a plan comes together. On December 19th-- barely a month ago-- we alerted readers to an extremely unique nanotech biotechnology concern, Biophan (OTCBB: BIPH) at 35 cents. Monday morning, the shares hit $1.50—a 328 percent return in...
Profit Alert: Biophan; Nothing short of breathtaking. I love it when a plan comes together. On December 19th-- barely a month ago-- we alerted readers to an extremely unique nanotech biotechnology concern, Biophan (OTCBB: BIPH) at 35 cents. Monday morning, the shares hit $1.50—a 328 percent return in...
December 2003
Trading Alert: Biophan Technologies
December 19, 2003
Trading Alert: Biophan Technologies If you don’t currently know someone with a pacemaker, cardiac stent or other implanted medical device, you will. That person may even be you. As the population ages, one thing is irrefutable: more implanted medical devices will be needed. But there’s a big problem...
Trading Alert: Biophan Technologies If you don’t currently know someone with a pacemaker, cardiac stent or other implanted medical device, you will. That person may even be you. As the population ages, one thing is irrefutable: more implanted medical devices will be needed. But there’s a big problem...
